PMID: 9557158Apr 29, 1998Paper

Expression of 70-kDa heat-shock protein during acute graft-versus-host disease

Clinical Immunology and Immunopathology
J GoralJ Clancy

Abstract

Acute lethal graft-versus-host disease (GVHD) was induced in unirradiated (LEW x DA)F1 rats by injection of DA parental lymphoid cells. Control rats received the same dose of (LEW x DA)F1 cells. The level of hsp70 at different stages of GVHD was examined in the spleen, lymph nodes, thymus, liver, lung, kidney, heart, and skeletal muscles of GVHD and control animals. Hsp70 was present in all organs analyzed in both groups and, with the exception of the spleen and lymph nodes, detectable levels remained constant during the disease. However, the spleen and lymph nodes of GVHD rats showed distinct changes in the hsp70 levels throughout the course of the disease. Expression of hsp70 in spleen and lymph nodes was augmented 7 and 14 days after induction of the disease. During the last stages of GVHD, 18-21 days after the induction, expression of hsp70 diminished to a level similar to that in untreated and control animals. Elevated levels of hsp70 in lymphoid organs during GVHD suggest an involvement of hsp70 in the pathology of the disease.

References

Jan 1, 1992·International Journal of Clinical & Laboratory Research·S H Kaufmann
Jul 15, 1992·Experientia·C BurelM Morange
Dec 1, 1989·The Journal of Experimental Medicine·A VanbuskirkS K Pierce
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D K FerrisW L Farrar
Jan 1, 1984·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·R M KleinK Sheridan
Jun 1, 1995·American Journal of Clinical Pathology·J A BombíA Cardesa
Jun 1, 1993·International Immunology·C S Via, F D Finkelman
Feb 1, 1996·The Journal of Experimental Medicine·E NossnerA M Krensky
Aug 1, 1996·Journal of the American Academy of Dermatology·R G LangleyG Rowden
Dec 1, 1995·Neuropathology and Applied Neurobiology·C Linington
Sep 1, 1996·The Journal of Investigative Dermatology·A C GilliamG F Murphy
Sep 1, 1996·Stem Cells·J L FerraraW Krenger

❮ Previous
Next ❯

Citations

Oct 30, 1999·The Annals of Thoracic Surgery·J LoCiceroL Zhang
Apr 8, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Thi Thu Hien NguyenIlona Hromadnikova
Jan 18, 2013·Autoimmune Diseases·Pawel Stocki, Anne M Dickinson
Feb 24, 2016·Human Immunology·Petya Apostolova, Robert Zeiser
Apr 29, 1998·Clinical Immunology and Immunopathology·S N LiossisG C Tsokos
Nov 17, 1998·The Journal of Urology·R MathewsJ P Gearhart
Dec 15, 2016·Frontiers in Immunology·Tomomi ToubaiPavan Reddy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Indian Journal of Dermatology, Venereology and Leprology
Mahesh K Kumawat, Sujay Khandpur
Clinical Medicine : Journal of the Royal College of Physicians of London
Nicholas W Morrell, Carol M Black
© 2022 Meta ULC. All rights reserved